Haoxi Health Technology Limited announced a 1-for-20 reverse share split of its Class A and Class B ordinary shares. The split-adjusted trading will begin on Nasdaq on August 14, 2026, under the symbol HAO with a new CUSIP number. The reverse split will reduce outstanding Class A ordinary shares from 11,904,632 to approximately 595,232 and Class B ordinary shares from 317,897 to approximately 15,895. No fractional shares will be issued, with fractional interests rounded up to the nearest whole share. The company expects the share price to trade at approximately 20 times the pre-split price, though it cannot guarantee that level will be maintained.
Haoxi Health Technology LimitedReverse split is a capital restructuring; impact on share price is mechanical and uncertain.
